Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-23-051941

President and CEO gave up 8,549 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-02 Shares withheld for taxes : show line 1 in the form −8,549 $3.83 $32,743 43,884 D
Loading xslF345X05/doc4.xml…